EBITDA add-backs, explained
EBITDA add-backs are adjustments a company makes to its reported earnings to produce a higher "adjusted EBITDA" figure. The logic is that certain expenses in reported results are one-time, non-recurring, or non-operational, and so should be added back to arrive at the "real" earnings power of the business. In private equity, add-backs are how sellers justify higher asking prices, how buyers model future returns, and how lenders size debt. Add-backs for things like restructuring costs, a one-time legal settlement, or pre-acquisition owner's personal expenses are legitimate. Add-backs for things that keep happening every year are not. The gap between these two categories, and the industry's willingness to push the line, is where add-backs become a problem.
That is the textbook answer. Here is what actually happens.
The basic idea, in numbers
A company reports $80 million of EBITDA. The seller wants to sell at 10x, which implies a $800 million enterprise value. A PE firm considering the deal wants to pay 10x of $60 million, for $600 million, because they think $20 million of the company's recurring cost base is being mischaracterised.
The seller's banker builds a "quality of earnings" report that argues for $100 million of adjusted EBITDA. The banker adds back:
- $7m of owner's compensation above market (the founder paid himself $10m when a market-rate CEO would cost $3m)
- $4m of one-time restructuring from a facility consolidation
- $3m of legal fees from a lawsuit that settled
- $3m of IT investment that is capex in disguise
- $3m of "run-rate synergies" from a recent acquisition the company has not actually captured yet
Now the company has $100m of adjusted EBITDA. At 10x, the ask is $1 billion.
The PE buyer, running their own LBO model, does their own quality-of-earnings review and pushes back on most of those add-backs. They accept the owner's compensation and the legal settlement. They reject the restructuring (it is ongoing, not one-time) and the run-rate synergies (unrealised). They view the IT investment as real capex that should not be in EBITDA.
Their adjusted EBITDA is $90m. At 10x, they can justify $900 million. Seller and buyer negotiate, land at $950 million, and the deal closes on adjusted EBITDA of $95m at a 10x multiple.
That is the game.
The legitimate add-backs
Not all add-backs are reaches. There are adjustments that honestly reflect how the business will operate under PE ownership.
Owner's compensation above market. A founder paying himself $8 million when the role is worth $2 million is overpaying himself, and PE ownership will normalise this. Adding back $6 million is reasonable, assuming the PE firm actually hires a replacement CEO at market rate.
True one-time legal and settlement costs. A discrete lawsuit that has settled is not going to recur. Adding it back is reasonable, provided the company is not in a sector where litigation is chronic.
Stock-based compensation. If the company is private but has been paying equity-based comp as retention (unusual but happens), the PE buyer may replace it with cash comp of equivalent value. Adding back the SBC and subtracting the new cash comp nets out honestly.
Owner's personal expenses. A private company often has the founder's car, personal travel, and similar expenses flowing through the P&L. Under PE ownership these go away. Adding them back is legitimate if clearly documented.
Discontinued operations. A line of business the company has already wound down should have its historical losses added back, because they are not part of the go-forward business.
These are all the defensible ones. Together they might produce $5-10m of add-backs on a $70m EBITDA company. The optics are fine.
The controversial add-backs
Where it gets interesting is the adjustments that live in the grey zone.
Restructuring costs. A company doing a big cost program in year 1 (of 3) might add back the restructuring charges as "one-time". But if the company has done restructuring charges every year for four years, it is not one-time. It is the operating reality.
IT and cybersecurity investment. When a company capitalises IT investments that should be expensed (or vice versa), add-backs can be used to move costs between categories. A $5m annual cybersecurity spend that the company claims is "one-time platform investment" is probably recurring.
Deferred maintenance. Manufacturing and industrials businesses sometimes add back the costs of maintenance they should have been doing all along. A new PE buyer who then has to spend $10m to catch up on maintenance in year 1 has inherited a liability.
Pre-synergy pro forma. When the company acquired something in year -1 and claims "pro forma" EBITDA including synergies that would have happened if the acquisition had closed earlier, the resulting number is a projection dressed as a historical.
Pre-acquisition period EBITDA from an add-on. "Year 0 EBITDA includes 12 months from a company we acquired in month 9." That is not year 0 EBITDA; it is a mash-up.
These live in the grey zone because they can be defensible or indefensible depending on the specific facts. Sophisticated buyers interrogate them. Less-sophisticated buyers (less-experienced diligence teams, covenant-hungry lenders) accept them.
The indefensible add-backs
There are also the add-backs that nobody should accept but that get into deal documents anyway.
"Run-rate" synergies that have not been realised. Adding back $20m of future synergies to today's EBITDA is adding future value to a historical number. In the worst cases, these are just fictional cost cuts.
COVID adjustments, several years later. Adding back "lost COVID revenue" in 2025 is a reach. Even in 2021 these were aggressive.
Missed budget add-backs. "We would have done $90m of EBITDA if the team had executed better." This is a hope, not a fact.
Customer concentration adjustments. "If our biggest customer had not churned, EBITDA would have been higher." That customer churned; it is reality.
Founder anecdote adjustments. "The founder thinks this was a one-time bad year." The founder is selling; his view is not neutral.
Why the buy-side still accepts bad add-backs
Given how obviously some add-backs are reaches, why do PE firms still buy companies priced on them?
Three reasons.
Competitive process pressure. Auctions create price pressure. A buyer that aggressively challenges add-backs may lose the deal to a buyer that accepts them. Firms underwriting to aggressive add-backs win deals; firms underwriting to conservative numbers lose them. This is a selection problem: the winner's curse is real, and the winner is often the firm with the most generous view of the seller's adjustments.
Limited time for diligence. Modern sell-side processes give buyers 6-10 weeks of exclusive diligence. That is not enough to fully validate every line item. Bidders have to trust the seller's quality-of-earnings report to a significant degree.
The debt sizing feedback loop. Lenders size leverage as a multiple of adjusted EBITDA. If the buyer uses lower (more honest) EBITDA, their leverage capacity drops, their equity cheque has to go up, and the deal becomes less attractive on returns math. Accepting higher EBITDA cascades into a more fundable, higher-returning (on paper) deal. The pressure to accept the higher number is structural.
What bad add-backs do to a deal, long term
A PE firm that pays 10x of $100m adjusted EBITDA, where the "real" EBITDA is closer to $80m, has effectively paid 12.5x for the business. The LBO model assumed 10x entry, 12x exit, to generate a target return. But the entry was actually 12.5x, and the exit needs to be 15x to hit the same return, which is implausible.
In year 2, the company's "real" cash generation turns out to be $75m rather than the $100m the bank modelled. Debt service consumes most of it. There is nothing left for capex, working capital, or add-on acquisitions.
By year 4, the company is breaching covenants. The PE firm negotiates amendments. By year 5, the deal is underwater relative to original expectations, and the PE firm is choosing between a distressed sale or a continuation fund.
The add-backs did not make the company worse. They just pre-committed the PE firm to outcomes the business could not actually deliver.
How to read add-backs in a deal
If you are reading a PE deal announcement and the company is described with "$X million of adjusted EBITDA", the critical questions are:
What is the gap between reported and adjusted EBITDA? A 5-10% gap is normal. 15-20% is starting to look generous. 25%+ is a structural tell.
What categories make up the add-backs? Owner's compensation and one-time legal are benign. Restructuring and synergies are where the problems live.
What is the multi-year pattern? If the seller has been adding back "one-time" items every year for four years, they are recurring.
What is the leverage multiple on reported vs adjusted? A deal at 6.0x adjusted EBITDA that is 7.5x reported EBITDA is more levered than it looks.
The closing take
EBITDA add-backs are a necessary part of how private companies are valued and sold. The logic is sound: reported numbers include real noise, and adjusting for that noise produces a cleaner operating picture.
The problem is that add-backs have become a negotiating instrument rather than an analytical one. Sellers push them to justify asking prices. Buyers accept them to win deals. Lenders size debt against them. When deals work, nobody notices. When deals fail, the add-backs are usually part of the autopsy.
The industry has resisted every attempt to standardise add-back methodology, because the flexibility to define them is commercially valuable. Expect this to continue.
If you want to read a quality-of-earnings report honestly, the simplest test is: would these costs recur if the company kept running under its current ownership? If yes, they are not one-time, and they should not be added back.
For more on how PE pricing actually works, see the LBO model. For how add-backs interact with dividend recaps, PIK financing, sale-leasebacks, see the rest of the toolkit. For the bigger picture, start with what is private equity.
